Evidence map›Paper›PMID 41742217›Full record

ArticleOrphanet journal of rare diseases2026

Generation and characterization of a novel Gaa compound heterozygous mouse model recapitulating human Pompe disease.

Wenjun Huang, Jie Wang, Yafei Zhou, Hongyu Xiao, Kaichong Jiang, Jiale Cui, Yanmin Zhang, Rui Zhou

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjun HuangNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China.
Jie WangNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China.
Yafei ZhouNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China.
Hongyu XiaoDepartment of Cardiology, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi' an Jiaotong University, Xi'an, China.
Kaichong JiangNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China.
Jiale CuiSchool of Basic Medical of Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
Yanmin ZhangNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China. ymzh628@126.com.
Rui ZhouNational Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, China. zhouhuaxizhu@126.com.ORCID http://orcid.org/0000-0001-7638-1442

Funding

National Natural Science Foundation of China No.82200399Natural Science Foundation of Shaanxi Province 2025JC-YBMS-876Natural Science Foundation of Shaanxi Province 2025JC-YBQN-1203Natural Science Foundation of Xi'an Children's Hospital No.2022G15Natural Science Foundation of Xi'an Children's Hospital No.2024B02Natural Science Foundation of Xi'an Children's Hospital No.2024D01Shaanxi Provincial TCM Administration-Qinchuangyuan Initiative for Traditional Medicine Innovation 2022-QCYZH-020
6 · The paper itself

Abstract

backgroundPompe disease (PD), caused by a deficiency in acid α-glucosidase (GAA), is a lysosomal storage disorder. Existing Gaa knockout and point mutation mouse models have substantially advanced mechanistic understanding, but most are homozygous for single mutations and do not faithfully model the compound‑heterozygous GAA genotypes common in patients. A more clinically relevant in vivo model is still needed to enable systematic evaluation and faithful recapitulation of multi‑organ pathology. We previously reported an infantile-onset PD (IOPD) family carrying compound heterozygous GAA mutation (GAA c.1822 C > T/2662G > T; R608*/E888*). We here generated a novel compound heterozygous Gaa mouse model (Gaa c.1822 C > T/2665A > T; R608*/K889*), corresponding to human R608*/E888*), corresponding to human GAA identified in the IOPD family.

methodsCRISPR/Cas9-mediated knock-in introduced R608* (exon 14) and K889* (exon 18) mutations into C57BL/6 zygotes. Compound heterozygotes (CHet) were bred, validated via Sanger sequencing, and phenotyped using GAA activity assays, glycogen quantification, histopathology, transmission electron microscopy (TEM), and echocardiography. Parameters included cardiac structure/function, skeletal muscle integrity, hepatic glycogenosis, and diaphragmatic pathology.

resultsCHet mice exhibited reduced GAA activity and elevated plasma glycogen levels, recapitulating the metabolic hallmark of human PD. Systemic pathophysiological characterization revealed multi-organ dysfunction: the heart showed pronounced hypertrophy with structural remodeling, evidenced by thickened ventricular walls and sarcolemmal disarray, despite preserved compensatory function. Skeletal muscle pathology was marked by vacuolated myofibers, lysosomal glycogen accumulation, and mitochondrial abnormalities, reflecting impaired autophagic flux. Hepatic tissues displayed prominent glycogen storage, hepatocyte swelling, and disrupted cellular architecture. Diaphragmatic dysfunction, a critical determinant of respiratory failure in PD, was characterized by vacuolation, nuclear centralization, and inflammatory infiltration, with ultrastructural evidence of lysosomal glycogen deposition and mitochondrial damage across all tissues.

conclusionsTo our knowledge, this is among the first compound heterozygous Gaa mouse models integrating East Asian-specific GAA mutations (R608*/E888*) and demonstrating multi-organ pathophysiology similar to human PD. By preserving residual GAA activity (~ 18%) and recapitulating cardiac, skeletal, hepatic, and respiratory defects, our model provides an important complementary platform for elucidating mutation-specific mechanisms, optimizing enzyme replacement therapy (ERT), and advancing gene-editing strategies. Its alignment with patient-derived iPSC findings enhances the translational relevance of research in PD and lysosomal disorders.

Indexed as

alpha-GlucosidasesGlycogen Storage Disease Type IIAnimalsDisease Models, AnimalFemaleHeterozygoteHumansMaleMiceMice, Inbred C57BLMuscle, SkeletalMutationalpha-GlucosidasesCompound heterozygous mouse modelGAA mutationsHypertrophic cardiomyopathyMitochondrial dysfunctionPompe disease

Identifiers

PMID41742217
PMCPMC13040868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.